Literature DB >> 21391558

New figures of merit for comprehensive functional genomics data: the metabolomics case.

Marinus F Van Batenburg1, Leon Coulier, Fred van Eeuwijk, Age K Smilde, Johan A Westerhuis.   

Abstract

In the field of metabolomics, hundreds of metabolites are measured simultaneously by analytical platforms such as gas chromatography/mass spectrometry (GC/MS), liquid chromatography/mass spectrometry (LC/MS) and NMR to obtain their concentration levels in a reliable way. Analytical repeatability (intrabatch precision) is a common figure of merit for the measurement error of metabolites repeatedly measured in one batch on one platform. This measurement error, however, is not constant as its value may depend on the concentration level of the metabolite. Moreover, measurement errors may be correlated between metabolites. In this work, we introduce new figures of merit for comprehensive measurements that can detect these nonconstant correlated errors. Furthermore, for the metabolomics case we identified that these nonconstant correlated errors can result from sample instability between repeated analyses, instrumental noise generated by the analytical platform, or bias that results from data pretreatment.

Mesh:

Year:  2011        PMID: 21391558     DOI: 10.1021/ac102374c

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  7 in total

Review 1.  The use of mass spectrometry for analysing metabolite biomarkers in epidemiology: methodological and statistical considerations for application to large numbers of biological samples.

Authors:  Mads V Lind; Otto I Savolainen; Alastair B Ross
Journal:  Eur J Epidemiol       Date:  2016-05-26       Impact factor: 8.082

2.  Revisiting Protocols for the NMR Analysis of Bacterial Metabolomes.

Authors:  Steven Halouska; Bo Zhang; Rosmarie Gaupp; Shulei Lei; Emily Snell; Robert J Fenton; Raul G Barletta; Greg A Somerville; Robert Powers
Journal:  J Integr OMICS       Date:  2013-12

3.  Harmonization of quality metrics and power calculation in multi-omic studies.

Authors:  Sonia Tarazona; Leandro Balzano-Nogueira; David Gómez-Cabrero; Andreas Schmidt; Axel Imhof; Thomas Hankemeier; Jesper Tegnér; Johan A Westerhuis; Ana Conesa
Journal:  Nat Commun       Date:  2020-06-18       Impact factor: 14.919

4.  Exploring dynamic metabolomics data with multiway data analysis: a simulation study.

Authors:  Lu Li; Huub Hoefsloot; Albert A de Graaf; Evrim Acar; Age K Smilde
Journal:  BMC Bioinformatics       Date:  2022-01-10       Impact factor: 3.169

5.  Development and validation of a robust automated analysis of plasma phospholipid fatty acids for metabolic phenotyping of large epidemiological studies.

Authors:  Laura Yun Wang; Keith Summerhill; Carmen Rodriguez-Canas; Ian Mather; Pinal Patel; Michael Eiden; Stephen Young; Nita G Forouhi; Albert Koulman
Journal:  Genome Med       Date:  2013-04-25       Impact factor: 11.117

Review 6.  Metabolomics and systems pharmacology: why and how to model the human metabolic network for drug discovery.

Authors:  Douglas B Kell; Royston Goodacre
Journal:  Drug Discov Today       Date:  2013-07-26       Impact factor: 7.851

7.  Fusing metabolomics data sets with heterogeneous measurement errors.

Authors:  Sandra Waaijenborg; Oksana Korobko; Ko Willems van Dijk; Mirjam Lips; Thomas Hankemeier; Tom F Wilderjans; Age K Smilde; Johan A Westerhuis
Journal:  PLoS One       Date:  2018-04-26       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.